Preferred Label : tumor necrosis factor-alpha;

MeSH definition : Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.;

MeSH synonym : tumor necrosis factor; cachectin tumor necrosis factor; cachectin-tumor necrosis factor; TNFalpha; tumor necrosis factor ligand superfamily member 2; cachectin; tnf superfamily, member 2; tumor necrosis factor alpha; TNF-alpha;

Wikipedia link : https://en.wikipedia.org/wiki/Tumor necrosis factor;

Is substance : O;

Details


Main resources

You can consult :

Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS.

https://dumas.ccsd.cnrs.fr/dumas-04327146
2023
France
dissertations, academic
patients
answering services
spondylarthritis
principal
filing
tumor necrosis factor-alpha
disease
Interleukin-17
has patient

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-utilisation-biosimilaires-anti-tnf-alpha
2022
France
Biosimilars
anti-TNF
France
France
France
biosimilar pharmaceuticals
tumor necrosis factor alpha
france
french
France
tumor necrosis factor-alpha

---
https://www.cochrane.org/fr/CD012448/les-inhibiteurs-du-tnf-compares-au-placebo-ou-en-association-chez-les-enfants-atteints-de-la-maladie
2019
false
false
false
France
United Kingdom
Tumor necrosis factor alpha (TNF-α) inhibitors
mucocutaneous lymph node syndrome
treatment outcome
review of literature
french abstract
mucocutaneous lymph node syndrome
child
placebos
tumor necrosis factor-alpha
Tumor Necrosis Factor Inhibitors

---
https://dumas.ccsd.cnrs.fr/dumas-01952987/document
2018
France
dissertations, academic
pharmacies
patient education as topic
tumor necrosis factor-alpha
interview
interview

---
http://www.sudoc.fr/232421579
2018
false
false
false
France
dissertations, academic
patients
Vaccination Coverage
tumor necrosis factor-alpha
cohort studies
has patient
tumor necrosis factor alpha
therapeutics
anti-TNF
preventive immunization/medication

---
http://www.sudoc.fr/199443343
2016
false
false
false
France
French
recommendations, health planning
directive counseling
Off-Label use
guideline adherence
spondylarthropathies
tumor necrosis factor-alpha
dissertations, academic

---
Summary Safety Review - Tumour Necrosis Factor (TNF) alpha blockers (SIMPONI and CIMZIA) - Assessing the Potential Risk of Liver Inflammation (Autoimmune Hepatitis)
https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/tnf-fnt-2-fra.php
2016
false
false
false
Canada
French
tumor necrosis factor-alpha
drug evaluation
risk assessment
hepatitis, autoimmune
canada
Tumor necrosis factor alpha (TNF-α) inhibitors
psoriasis
arthritis, rheumatoid
crohn disease
colitis, ulcerative
golimumab
Certolizumab Pegol
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors

---
https://www.jle.com/fr/revues/hpg/e-docs/les_manifestations_cutanees_des_anti_tnf_alpha_305568/article.phtml
2015
false
false
false
France
French
journal article
tumor necrosis factor-alpha
tumor necrosis factor-alpha
case reports
image
skin diseases
algorithms
examination questions
Dermatitis psoriasiform
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance)
Tumor Necrosis Factor Inhibitors

---
https://dumas.ccsd.cnrs.fr/dumas-01253135
2015
false
false
false
France
French
dissertations, academic
uveitis
tumor necrosis factor alpha
Treatment Efficacy
has patient
patients
tumor necrosis factor-alpha
retrospective studies
therapeutics
panuveitis
effective
treatment outcome

---
http://www.sudoc.fr/192195689
2015
false
false
false
France
French
dissertations, academic
tumor necrosis factor-alpha
risk
occupational
review literature
occupational exposure
tumor necrosis factor alpha
review
anti-infective agents
effects of exposure to external cause, nos
review literature as topic
proband
review

---
https://pharmacomedicale.org/medicaments/par-specialites/item/anti-tnf-alpha
2015
false
false
false
France
French
drug information
tumor necrosis factor-alpha
Tumor necrosis factor alpha (TNF-α) inhibitors
Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance)
tumor necrosis factor-alpha
tumor necrosis factor alpha
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/jcms/c_1774629/fr/beromun
2014
false
false
false
France
French
evaluation of the transparency committee
Isolated Chemotherapeutic Limb Perfusion
chemotherapy, cancer, regional perfusion
extremities
tumor necrosis factor-alpha
adult
hyperthermia, induced
antineoplastic combined chemotherapy protocols
melphalan
Soft Tissue Sarcoma
sarcoma
tasonermin
extremities
soft tissue neoplasms
palliative care
neoadjuvant therapy
treatment outcome

---
http://www.sfdermato.org/media/pdf/recommandation/traitements-anti-tnf-recos-64222d1c6f9c32cb666ec9ac141d2349.pdf
2013
true
France
French
continuity of patient care
autoimmune diseases
risk assessment
neoplasms
mass screening
neoplasms
hematologic diseases
herpesviridae infections
herpesvirus 3, human
herpes simplex
malaria
histoplasmosis
legionellosis
hepatitis B
hepatitis C
vaccines
vaccination
pregnancy
surgical procedures, operative
aged
tumor necrosis factor-alpha
guidelines for drug use
journal article
antibodies, monoclonal
antibodies, monoclonal
antirheumatic agents
antirheumatic agents
Tumor necrosis factor alpha (TNF-α) inhibitors
Tumor Necrosis Factor Inhibitors

---
https://www.revmed.ch/RMS/2013/RMS-384/Immunosuppresseurs-usages-systemiques-et-neurologiques
2013
false
Switzerland
French
immunosuppressive agents
journal article
tumor necrosis factor-alpha
immunologic factors
Rituximab

---
https://www.ema.europa.eu/medicines/human/EPAR/Beromun
2011
false
United Kingdom
English
French
extremities
soft tissue neoplasms
syndication feed
antineoplastic combined chemotherapy protocols
tumor necrosis factor-alpha
chemotherapy, cancer, regional perfusion
antineoplastic agents
melphalan
sarcoma
tasonermin
immunologic factors
package leaflet
summary of product characteristics
drug evaluation

---
https://rmlg.uliege.be/article/2155
2011
false
true
false
Belgium
excitatory amino acid agents
depression
depression
depressive disorder
depressive disorder
tumor necrosis factor-alpha
journal article
excitatory amino acid agents
antidepressive agents
Tumor Necrosis Factor Inhibitors

---
http://www.lecrat.eu/?s=Anti-TNF+alpha+et+fin+de+grossesse
2011
France
drug information
pregnancy, nos
pregnancy
tumor necrosis factor-alpha

---
https://www.revmed.ch/RMS/2011/RMS-277/Rhumatologie.-ANTI-TNFa-quels-risques-infectieux-Recommandations-pratiques
2011
Switzerland
French
journal article
rheumatic diseases
tumor necrosis factor-alpha
tumor necrosis factor-alpha
tumor necrosis factor-alpha
Infections
Tumor Necrosis Factor Inhibitors

---
http://www.cochrane.org/fr/CD008088
2010
United Kingdom
France
French
Cancer Pain
review of literature
endometriosis
pelvic pain
treatment outcome
tumor necrosis factor-alpha
anti-inflammatory agents
french abstract
Tumor Necrosis Factor Inhibitors

---
http://www.sfdermato.org/media/pdf/fmc/antitnfalpha2-667890231491e9d8d372693646727425.pdf
2010
false
false
false
France
journal article
tumor necrosis factor-alpha
skin manifestations

---
https://www.cadth.ca/fr/les-anti-tnf-dans-la-prise-en-charge-des-maladies-inflammatoires-chroniques-de-lintestin
https://www.cadth.ca/sites/default/files/pdf/O0479_Anti_TNF_a_Drugs_for_Refractory_Inflammatory_Bowel_Disease_to_fr.pdf
2009
true
Canada
English
French
Adalimumab
Infliximab
tumor necrosis factor-alpha
Cost-Benefit analysis
drug costs
treatment outcome
gastrointestinal agents
gastrointestinal agents
crohn disease
proctocolitis
anti-inflammatory agents
anti-inflammatory agents
canada
randomized controlled trials as topic
patient care management
immunoglobulin G
receptors, tumor necrosis factor
drug evaluation
economic evaluation
comparative study
Tumor Necrosis Factor Inhibitors

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/45/BA/resume.phtml?type=text.html
2009
France
French
journal article
antineoplastic agents
chemotherapy, cancer, regional perfusion
melphalan
pelvic neoplasms
tumor necrosis factor-alpha

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2009/13327a-fra.php
2009
Canada
English
French
antirheumatic agents
neoplasms
tumor necrosis factor-alpha
child
drug labeling
pharmacovigilance note
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/jcms/c_886848/spondylarthrites-traitement-et-suivi-argumentaire
http://www.has-sante.fr/portail/jcms/c_800266/diagnostic-prise-en-charge-therapeutique-et-suivi-des-spondylarthrites
http://www.has-sante.fr/portail/jcms/c_886846/spondylarthrites-diagnostic-argumentaire
2008
false
false
Haute Autorité de santé
France
French
Adrenocortical steroid therapy
corticosteroid therapy
french abstract
spondylarthritis
diagnostic imaging
consumer health information
pregnancy
spondylarthritis
spondylarthritis
spondylarthritis
spondylarthritis
anti-inflammatory agents, non-steroidal
adrenal cortex hormones
tumor necrosis factor-alpha
arthritis, psoriatic
continuity of patient care
severity of illness index
clinical trials as topic
practice guideline
spondylarthritis
Tumor Necrosis Factor Inhibitors

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F34F08H
2007
Belgium
French
tumor necrosis factor-alpha
receptors, tumor necrosis factor
arthritis, rheumatoid
antirheumatic agents
immunoglobulin G
antibodies, monoclonal
neoplasms
pharmacovigilance note
journal article
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/display.jsp?id=c_606483
http://www.has-sante.fr/portail/display.jsp?id=c_608766
2007
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
arthritis, rheumatoid
arthritis, rheumatoid
methotrexate
antirheumatic agents
glucocorticoids
tumor necrosis factor-alpha
anti-inflammatory agents, non-steroidal
phytotherapy
continuity of patient care
arthritis, rheumatoid
antibodies, monoclonal
immunoconjugates
interleukin 1 receptor antagonist protein
practice guideline
retraction of publication
Tumor Necrosis Factor Inhibitors

---
http://revmed.ch/RMS/2006/RMS-82/31727
2006
true
Switzerland
French
Adalimumab
Infliximab
tuberculosis
risk factors
tumor necrosis factor-alpha
leukopenia
arthritis, rheumatoid
Infections
Tumor necrosis factor alpha (TNF-α) inhibitors
immunoglobulin G
receptors, tumor necrosis factor
journal article
drug information
Tumor Necrosis Factor Inhibitors

---
https://www.cadth.ca/sites/default/files/pdf/108_No42_adalimumab_edrug_f.pdf
2003
false
Canada
French
Adalimumab
Adalimumab
tumor necrosis factor-alpha
arthritis, rheumatoid
united states
canada
clinical trials as topic
drug evaluation
Tumor Necrosis Factor Inhibitors

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.